• Click Here to read, Letter by Puri et al Regarding Article, “Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control”
• Click Here to read, American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice are systematically developed statements to assist health care professionals in medical decision-making for specific clinical conditions but are in no way a substitute for a medical professional’s independent judgment and should not be considered medical advice.
• Click Here to read, AACE & ACE issued new lipid-management guidelines that bring back LDL-cholesterol “targets” and are the first ever to include a new “extreme-risk” category of patients, for
  whom an LDL-cholesterol level of less than 55 mg/dL is now advised.